Tumblr Yahoos: Old ...
Health Care: Drugs
Acorda Therapeutics Inc. (ACOR: NASDAQ)
$32.16 -0.78 | -2.37%
05/20/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 154.96M | 30.60M | -11.77M | -83.94M |
| Operating Gains/Losses | -701.00K | 639.00K | -246.50K | 284.60K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -3.50M | -556.00K | -16.53M | -1.12M |
| (Increase) Decrease in Inventories | 7.43M | 10.04M | -31.53M | -618.66K |
| (Increase) Decrease In Other Current Assets | 0.00 | -372.00K | -878.00 | 6.28K |
| (Decrease) Increase In Payables | 11.74M | -6.11M | 24.71M | 2.22M |
| (Decrease) Increase In Other Current Liabilities | -725.00K | -1.14M | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | -12.28M | -7.22M | -8.25M | 105.05M |
| Other Non-Cash Items | 22.08M | 32.34M | 17.78M | 12.28M |
| Net Cash From Continuing Operations | 52.12M | 66.34M | -19.22M | 38.63M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 52.12M | 66.34M | -19.22M | 38.63M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 264.75M | 227.50M | 325.75M | 296.40M |
| Purchases of Property, Plant & Equipment | -13.58M | -5.79M | -9.44M | -2.43M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -322.46M | -266.74M | -310.95M | -310.38M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -71.28M | -45.02M | 5.35M | -16.41M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 4.34M | 3.96M | 8.37M | 2.54M |
| Repayment of Long-Term Debt | -1.25M | -1.96M | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | -328.76K | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | -6.85M | -7.07M |
| Net Cash From Financing Activities | 3.09M | 2.00M | 1.19M | -4.53M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -16.08M | 23.31M | -12.67M | 17.70M |
Portfolios with ACOR
- Portfolio NameUser Type
- UserMike Fatah's Mega Stock Por...
- ContributorStocks Rising On Unusual Vo...
- UserWatch
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor13 Biotech Stocks Bought an...
- Contributor5 Biotech Drug-Launch Stock...
- Usergrandpicks
- UserPART 1 JPMorgan 28th Annual...
- ContributorBarron's Research Reports 3...
Latest ACOR Headlines from TheStreet
- Acorda Drug Helps Stroke Patients Walk Better 04.15.13 | 07:04 am
- Acorda Therapeutics Inc. Stock Upgraded (ACOR) 01.23.13 | 04:01 am
- Cramer's Top Stock Picks: UTX ACOR CRL AA 01.10.13 | 06:01 am
- Cramer's 'Mad Money' Recap: Bright Spots 01.09.13 | 07:01 pm
- Stock Futures Fall as Sandy Forces Market Closures 10.29.12 | 09:10 am
- 8 Stocks Soaring With Strong Volume 08.13.12 | 03:08 pm
- Cramer's 'Mad Money' Recap: A 'Hopium' Rally 06.19.12 | 08:06 pm
- FDA More Problematic Than Obamacare, Says Acorda CEO
04.24.12 | 06:04 am - BIO CEO Confab Live Blog: Day 2 02.14.12 | 10:02 am
- BIO CEO Conference Live Blog 02.13.12 | 01:02 pm
Press Releases for ACOR
- Diazepam Nasal Spray Demonstrates Comparable Bioavailability To Diazepam Rectal Gel In Pharmacokinetic Study - Business Wire 03.20.13 | 07:03 am
- Acorda To Present New Research On Novel Multiple Sclerosis And Epilepsy Therapies At American Academy Of Neurology 65th Annual Meeting - Business Wire 03.13.13 | 07:03 am
- Data From First Clinical Trial Of GGF2 In Heart Failure Presented At The American College Of Cardiology 62nd Annual Scientific Session - Business Wire 03.07.13 | 11:03 am
- Acorda Therapeutics To Present At The Cowen & Company 33rd Annual Health Care Conference - Business Wire 02.25.13 | 07:02 am
- Acorda Therapeutics To Present At RBC Capital Markets And Citi 2013 Global Healthcare Conferences - Business Wire 02.19.13 | 07:02 am
- Acorda Therapeutics Announces Company Intranet Named One Of Ten Best In The World - Business Wire 02.14.13 | 07:02 am
- Acorda Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results - Business Wire 02.13.13 | 06:02 am
- Acorda Therapeutics To Present At Leerink Swann Global Healthcare Conference - Business Wire 02.07.13 | 07:02 am
- Acorda Therapeutics Presents GGF2 Preclinical Stroke Data At International Stroke Conference - Business Wire 02.07.13 | 07:02 am
- Acorda Therapeutics To Host Conference Call To Discuss Fourth Quarter And Full Year 2012 Financial Results On February 13, 2013 - Business Wire 02.06.13 | 06:02 am
Partner Headlines for ACOR
- Biotech Alkermes Poised To Swell On Pipeline Wins - Investor's Business Daily 04.16.13 | 05:04 pm
- Acorda: A Biotech Company To Consider - Seeking Alpha 04.13.13 | 09:04 am
- Acorda Beats on All Fronts - Analyst Blog - Zacks 11.02.12 | 09:11 am
- After Hours Most Active for Oct 4, 2012 : SUN, PETM, AMAT, QQQ, CAB, ACOR, NVDA, BAC, ORCL, A, NOK, HPQ - NASDAQ 10.04.12 | 08:10 pm
- Back to Neutral on Alkermes - Analyst Blog - NASDAQ 09.18.12 | 09:09 pm
- Acorda Reports Data on Ampyra study - Analyst Blog - Zacks 08.14.12 | 05:08 pm
- Pre-Market Earnings Report for July 31, 2012 : BP, ADM, AET, AMG, WTR, BRKR, AVX, AUXL, ACOR, ALLT, CPLP, ABFS - NASDAQ 07.30.12 | 08:07 pm
- Revenues Climb at Acorda - Analyst Blog - Zacks 05.04.12 | 06:05 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 04.17.12 | 09:04 am
- Biogen's Fampyra Launched in Canada - Analyst Blog - Zacks 04.13.12 | 06:04 pm
